Peroxisome Proliferator-Activated Receptor and Retinoic X Receptor in Alcoholic Liver Disease

A growing number of new studies demonstrate that nuclear receptors are involved in the development of alcoholic liver disease (ALD). Ethanol metabolism and RXR/PPAR functions are tightly interconnected in the liver. Several ethanol metabolizing enzymes are potently regulated by RXR and PPAR𝛼 after a...

Full description

Bibliographic Details
Published in:	PPAR Research
Main Authors:	Tommaso Mello, Simone Polvani, Andrea Galli
Format:	Article
Language:	English
Published:	Wiley 2009-01-01
Online Access:	http://dx.doi.org/10.1155/2009/748174

Similar Items

Peroxisome proliferator–activated receptor delta and liver diseases
by: Tomoo Yamazaki, et al.
Published: (2025-02-01)

The role of peroxisome proliferator-activated receptor in the treatment of non-alcoholic fatty liver disease
by: Sun Xin, et al.
Published: (2017-03-01)

Pemafibrate modulates peroxisome proliferator-activated receptor alpha and prevents alcohol-associated liver disease in rats
by: Takashi Saito, et al.
Published: (2025-04-01)

Peroxisome Proliferator-Activated Receptors and Their Novel Ligands as Candidates for the Treatment of Non-Alcoholic Fatty Liver Disease
by: Anne Fougerat, et al.
Published: (2020-07-01)

Peroxisome Proliferator-Activated Receptors Associated with Nonalcoholic Fatty Liver Disease
by: Nan Wang, et al.
Published: (2017-01-01)

Chondrosarcoma and Peroxisome Proliferator-Activated Receptor
by: K. Hashizume, et al.
Published: (2008-01-01)

Peroxisome proliferator-activated receptors, farnesoid X receptor, and dual modulating drugs in hypertension
by: John D. Imig
Published: (2023-06-01)

Peroxisome Proliferator-Activated Receptors and Shock State
by: Emanuela Esposito, et al.
Published: (2006-01-01)

Peroxisome Proliferator Activated Receptors and Lipoprotein Metabolism
by: Sander Kersten
Published: (2008-01-01)

Peroxisome Proliferator-Activated Receptors in Diabetic Nephropathy
by: Shinji Kume, et al.
Published: (2008-01-01)

The role of peroxisome proliferator-activated receptors in endometriosis
by: Iason Psilopatis, et al.
Published: (2024-04-01)

The Role of Peroxisome Proliferator-Activated Receptors in Preeclampsia
by: Iason Psilopatis, et al.
Published: (2023-02-01)

Peroxisome Proliferator-Activated Receptors in Lung Cancer
by: Venkateshwar G. Keshamouni, et al.
Published: (2007-01-01)

Peroxisome Proliferator-Activated Receptors and the Hallmarks of Cancer
by: Nicole Wagner, et al.
Published: (2022-08-01)

The Role of Peroxisome Proliferator-Activated Receptors in Pulmonary Vascular Disease
by: Rachel E. Nisbet, et al.
Published: (2007-01-01)

Peroxisome Proliferator-Activated Receptor Targets for the Treatment of Metabolic Diseases
by: Francisco A. Monsalve, et al.
Published: (2013-01-01)

Role of Peroxisome Proliferator-Activated Receptor γ in Ocular Diseases
by: Su Zhang, et al.
Published: (2015-01-01)

Peroxisome Proliferator-Activated Receptors in Female Reproduction and Fertility
by: Maurizio Vitti, et al.
Published: (2016-01-01)

The Role of Peroxisome Proliferator-Activated Receptors in the Esophageal, Gastric, and Colorectal Cancer
by: Alessandra Fucci, et al.
Published: (2012-01-01)

Peroxisome proliferator-activated receptors gama ameliorates liver fibrosis in non-alcoholic fatty liver disease by inhibiting TGF-β/Smad signaling activation
by: Zhang Qingwei, et al.
Published: (2024-04-01)

Exserolide J ameliorates lipid accumulation in vitro by regulating liver X receptor alpha and peroxisome proliferator-activated receptor alpha proteins
by: Yan Zhang, et al.
Published: (2024-06-01)

Roles of the peroxisome proliferator-activated receptors (PPARs) in the pathogenesis of nonalcoholic fatty liver disease (NAFLD)
by: Yuan-Ye Qiu, et al.
Published: (2023-06-01)

Epigenetic Regulation of Peroxisome Proliferator-Activated Receptor Gamma Mediates High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease
by: Tahar Hajri, et al.
Published: (2021-05-01)

Peroxisome Proliferator-Activated Receptors in HBV-Related Infection
by: Laurent Dubuquoy, et al.
Published: (2009-01-01)

Peroxisome Proliferator-Activated Receptors in HCV-Related Infection
by: Sébastien Dharancy, et al.
Published: (2009-01-01)

Peroxisome Proliferator-Activated Receptors and Progression of Colorectal Cancer
by: Dingzhi Wang, et al.
Published: (2008-01-01)

Peroxisome Proliferator-Activated Receptors and Acute Lung Injury
by: Rosanna Di Paola, et al.
Published: (2007-01-01)

Peroxisome Proliferator-Activated Receptor Alpha Target Genes
by: Maryam Rakhshandehroo, et al.
Published: (2010-01-01)

Peroxisome Proliferator-Activated Receptor-γ in Thyroid Autoimmunity
by: Silvia Martina Ferrari, et al.
Published: (2015-01-01)

The Role of Peroxisome Proliferator-Activated Receptors in Colorectal Cancer
by: Joo-In Park, et al.
Published: (2012-01-01)

Peroxisome Proliferator-Activated Receptor Gamma Polymorphisms and Coronary Heart Disease
by: Jean Dallongeville, et al.
Published: (2009-01-01)

Potential therapeutic effects of peroxisome proliferator-activated receptors on corneal diseases
by: Bing Jie Chow, et al.
Published: (2024-06-01)

Peroxisome proliferator-activated receptors as stimulants of angiogenesis in cardiovascular disease and diabetes
by: Cyrus&nbsp;V Desouza, et al.
Published: (2009-09-01)

Modulation Effect of Peroxisome Proliferator-Activated Receptor Agonists on Lipid Droplet Proteins in Liver
by: Yun-Xia Zhu, et al.
Published: (2016-01-01)

Peroxisome Proliferator Activated Receptor Agonists Modulate Transposable Element Expression in Brain and Liver
by: Laura B. Ferguson, et al.
Published: (2018-09-01)

Peroxisome Proliferator-Activated Receptor Genetic Polymorphisms and Nonalcoholic Fatty Liver Disease: Any Role in Disease Susceptibility?
by: Paola Dongiovanni, et al.
Published: (2013-01-01)

Peroxisome Proliferator-Activated Receptor Modulation during Metabolic Diseases and Cancers: Master and Minions
by: Salvatore Giovanni Vitale, et al.
Published: (2016-01-01)

Peroxisome Proliferators-Activated Receptor (PPAR) Modulators and Metabolic Disorders
by: Min-Chul Cho, et al.
Published: (2008-01-01)

The Emerging Role of Peroxisome Proliferator-Activated Receptors in Cancer Stemness
by: Beatriz Parejo-Alonso, et al.
Published: (2025-10-01)

Peroxisome Proliferator-Activated Receptors as a Therapeutic Target in Asthma
by: Oxana Yu. Kytikova, et al.
Published: (2020-01-01)